Skip to Content
12

Inogen

  • Previous Rank-
  • Revenue 3 Yr Annual Growth Rate29%
  • Revenue 3 Yr Growth Rank46
  • EPS 3 Yr Annual Growth Rate52%
  • EPS 3 Yr Growth Rank33
  • Total Return 3 Yr Annual Rate61%
  • Total Return 3 Yr Rank5

Inogen is an oxygen device maker—which, on first glance, may not seem like the most riveting business. But the company’s return to shareholders and skyrocketing earnings growth are indisputable. In the second quarter of 2018, Inogen recorded revenues of more than $97 million—a nearly 52% year-over-year rise from the same period in 2017. The operating income growth will let the company engage in an aggressive hiring binge among its sales force, according to CEO Scott Wilkinson, and the stock is up nearly 95% year-to-date.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Information

Location
Goleta, Calif.
Industry
Medical Products & Equipment
Sector
Health Care
Current Streak-
Years on List1
CEO
Scott Wilkinson
Websitehttp://www.inogen.com
Revenue and net income for the four quarters ended on or before April 30, 2018. Total return for the period ended June 29, 2018.

Revenue, Net Income

Revenue past four quarters ($M)$276
Net Income past four quarters ($M)$26

Growth Rates and Ranks

Revenue 3 Yr Growth Rank46
Revenue 3 Yr Annual Growth Rate29%
EPS 3 Yr Growth Rank33
EPS 3 Yr Annual Growth Rate52%
Total Return 3 Yr Rank5
Total Return 3 Yr Annual Rate61%
Beat S&P 500 (11.9%)
yes
P/E Ratio113